| Literature DB >> 23383607 |
E Berntorp1, B Fuchs, M Makris, R Montgomery, V Flood, J S O'Donnell, A B Federici, D Lillicrap, P James, U Budde, M Morfini, P Petrini, S Austin, C Kannicht, V Jiménez-Yuste, C Lee.
Abstract
The first meeting of international specialists in the field of von Willebrand disease (VWD) was held in the Åland islands in 1998 where Erik von Willebrand had first observed a bleeding disorder in some members of a family from Föglö and a summary of the meeting was published in 1999. The second meeting was held in 2010 and a report of the meeting was published in 2012. Topics covered included progress in understanding of VWD over the last 50 years; multimers; classification of VWD; pharmacokinetics and laboratory assays; genetics; treating the paediatric patient; prophylaxis; geriatrics; gene therapy and treatment guidelines. This third meeting held over 3 days covered the structure and function of von Willebrand factor (VWF); type 1 VWD, the most common form of the disease; a lifespan of pharmacokinetics in VWD; detecting inhibitors in VWD patients; and special challenges in understanding and treating the female VWD patient.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23383607 PMCID: PMC4164969 DOI: 10.1111/hae.12078
Source DB: PubMed Journal: Haemophilia ISSN: 1351-8216 Impact factor: 4.287